Targeted delivery of molecules using impedance-based monitoring at elevated temperatures
View Patent ↗A method and system for delivering a molecule to a specific area of a tissue by controlling temperature and impedance is presented. The method is generally comprised of applying heat to a biological structure, such as cells or tissues, to heat the biological structure to a preset temperature after which at least one electroporation pulse is administered to the biological structure. Impedance is measured as a feedback control mechanism after each pulse and pulse parameters are adjusted accordingly until desired impedance is reached. The system generally comprises an electroporation system capable of generating at least one pulse, measuring impedance and measuring temperature.
1. A method of delivering a molecule to a biological structure of a subject comprising:
heating the biological structure to a preset temperature wherein the biological structure is heated by an element that is separate from electrodes used to apply at least one electroporation pulse;
measuring impedance of the biological structure to establish a preset impedance value;
applying the at least one electroporation pulse to deliver the molecule into the biological structure;
measuring the impedance of the biological structure as a feedback control mechanism after each pulse to determine permeability of cell membranes; and
adjusting pulse parameters based on the measured impedance of the biological structure until desired impedance is reached indicating delivery of the molecule to the biological structure;
wherein the desired impedance is at least a 10% reduction as compared to the preset impedance value.
2. The method of claim 1 , further comprising injecting a molecule into the biological structure prior to applying heat to the biological structure.
3. The method of claim 1 , further comprising monitoring temperature of the biological structure.
4. The method of claim 3 , wherein the temperature is monitored using impedance, thermal imaging, thermistors, thermocouples, thermopiles or combinations thereof.
5. The method of claim 1 , wherein the preset temperature is at least 35° C.
6. The method of claim 5 , wherein the preset temperature is between about 40° C. to about 46° C.
7. The method of claim 1 , wherein the heat applied to the biological structure is convective, conductive, radiative or combinations thereof.
8. The method of claim 1 , wherein the impedance feedback is measured in a frequency range of about 0 Hz to about 4 kHz.
9. The method of claim 1 , wherein the pulse parameters are selected from the group consisting of electric field intensity, pulse duration, pulse polarity, time interval between pulses, number of applied pulses, and combinations thereof.
10. The method of claim 9 , wherein the electric field intensity is between about 5 V/cm to about 2000 V/cm.
11. The method of claim 9 , wherein the pulse duration is between about 1 μs to about 1 second.
12. The method of claim 9 , wherein the time interval between pulses is between about 1 μs to about 1 second.
13. The method of claim 1 , wherein the molecule is selected from the group consisting of therapeutic drugs, genes, proteins, nucleic acid sequences, and plasmid DNA.
14. A method of delivering a molecule to a biological structure of a subject comprising:
injecting a molecule into the biological structure;
heating the biological structure to a preset temperature wherein the biological structure is heated by an element that is separate from electrodes used to apply at least one electroporation pulse;
measuring impedance of the biological structure to establish a preset impedance value;
applying the at least one electroporation pulse to deliver the molecule into the biological structure;
monitoring the temperature of the biological structure;
measuring impedance of the biological structure as a feedback control mechanism after each pulse to determine permeability of cell membranes; and
adjusting pulse parameters based on the measured impedance of the biological structure until desired impedance is reached indicating delivery of the molecule to the biological structure;
wherein the desired impedance is at least a 10% reduction as compared to the preset impedance value;
wherein the molecule is selected from the group consisting of therapeutic drugs, genes, proteins, nucleic acid sequences, and plasmid DNA;
wherein the pulse parameters are selected from the group consisting of electric field intensity, pulse duration, pulse polarity, time interval between pulses, number of applied pulses, and combinations thereof.